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HYPOTHESIS
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In a recent review, Weinberg (1989) has discussed apparent
violations of multistep carcinogenesis when in some cases full
transformation of primary cultures by single oncogenes (ras)
has been reported. Normally at least two co-operating onco-
genes such as myc and ras are thought necessary for full
transformation of primary cell cultures. Although there are
other possible factors to explain this apparent violation (e.g.
amplification of oncogene and destabilisation of the cells
genome by the oncogene/oncogene construct) it could be
explained, at least in part, by introducing another important
factor into the equation, that is the environment of the
oncogene-bearing cell. If an oncogene (e.g. ras) bearing cell is
surrounded by normal cells the latter exerts a normalising or
inhibitory influence on the growth of ras transformed cells.
When the presence and influence of the normal cells are
absent, then pure populations of ras transformed cells can
proliferate to produce large progeny clones. In vivo a possible
role of tumour promoters, such as TPA in mouse skin car-
cinogenesis, may be to allow the clonal expansion of rare
initiated cells with ras gene mutations which are surrounded
by normal cells (reviewed in Parkinson, 1985). Having popu-
lations of oncogene transformed ('initiated') cells in vitro
which are not surrounded by normal cells can be brought
about in at least two ways: (i) transfecting an oncogene
linked to a drug selection system which would result in the
drug killing of any normal cells resulting in a pure popula-
tion of 'initiated' cells; (ii) high multiplicity infection of nor-
mal monolayer cells by an oncogene-transducing virus which
spreads throughout the culture. In this latter situation ras
containing cells will be surrounded by ras containing cells
and the pure population of transformants will grow aggres-
sively as there are no normal cells to restrain their growth
(reviewed by Weinberg, 1989). These studies make a simple
but important point that the growth properties/potential of a
cell depends not only on its own genotype (e.g. its comple-
ment of oncogenes and/or tumour suppressor genes) but on
its own environment as well (Weinberg, 1989).
It is possible to make similar arguments about the im-
portance of the local environment when comparing tumour
development in sporadic versus hereditary cancers. Although
in this situation we are talking about the possible role of
tumour suppressor genes (anti-oncogenes) and not onco-
genes, nevertheless the same principles can apply, particularly
since we do not know the function and mode of action of
these tumour suppressor genes.
Most, if not all, cancers occur in sporadic and hereditary
forms and the argument about the importance of local envir-
onment can apply to all types ofcancers, including childhood
cancers such as Wilms' and retinoblastoma and the common
adult cancers. For the purpose of this article we shall con-
sider cancer of the human large intestine, which continues to
be a major cause of death in the industrialised world.
Colorectal cancer occurs in both sporadic and hereditary
forms and the most studied hereditary form is familial adeno-
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matous polyposis (FAP; also called familial polyposis coli).
During adolescence, individuals who have inherited the FAP
gene develop from a few hundred to over a thousand aden-
omas (premalignant tumours sometimes referred to as
polyps) in their large intestine. Unless treated, at least one or
more of these adenomas will progress to becoming carcin-
omas since most colorectal cancers, whether sporadic or
hereditary, are thought to arise from adenomas in what is
referred to as the adenoma carcinoma sequence (Muto et al.,
1975; Bussey, 1982).
Although there have been major developments in the mole-
cular biology of colorectal cancer, in particular the mapping
of the FAP gene to chromosome 5 (Bodmer et al., 1987;
Leppart et al., 1987) and the realisation that both activation
of dominantly acting oncogenes and loss of tumour suppres-
sor genes are involved in colorectal carcinogenesis (Solomon
et al., 1987; Vogelstein et al., 1988), important questions
remain. For example, what events are involved in the
development of colorectal adenomas, and are there different
events involved in the formation of hereditary versus
sporadic polyps? Although chromosome 5 allele loss has been
reported in some FAP adenomas (Rees et al., 1989), most
FAP adenomas do not show this loss of heterozygosity.
Chromosome 5 allele loss, however, occurred relatively com-
monly (29%) in adenomas from patients without polyposis
(Vogelstein et al., 1988). Although caution is required in that,
for example, current DNA probes may not be sufficiently
close to the FAP locus always to detect allele loss, this
implies that the development of adenomas, both hereditary
and sporadic, can occur even in the presence of one wild type
FAP allele, i.e. when the polyps are heterozygous at the FAP
locus. This is in contrast to the classical two mutation hypo-
thesis of Knudson (reviewed in Knudson, 1989) where in the
event of one mutation occurring in one allele no tumour
develops and only when the second allele of a tumour sup-
pressor gene is mutant or absent does the tumour occur.
Again caution is required because the kinetics and control of
cancer development in childhood cancers may be different
from in adult tumours and very little is known about possible
premalignant stages in the development of retinoblastoma.
However, if, as it appears, many adenomas do not show
allele loss, how does the heterozygous state therefore lead to
the development of the polyps? One possibility is through a
threshold effect involving, for example, negative control over
the production of growth factors (Bodmer et al., 1987) or
that in the heterozygous state a mutant suppressor gene
product (e.g. p53) may complex with the normal wild type
gene product and inactivate it (Finlay et al., 1989).
If (as seems to be the case, although it cannot be proven
until the gene is isolated) all FAP patients develop many
polyps, is the development ofthe polyps dependent simply on
the loss of a single allele of the FAP gene or are other events
involved? For example, in the classical mouse skin two-stage
model of carcinogenesis there is evidence that in some
systems ras gene mutations represent the initiation event but
this is insufficient for the formation of the benign papilloma
tumours and the application, after the initiation event, of the
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tumour promotor TPA is necessary for the development of
the papilloma (Brown et al., 1986). If the initiation event
(genetic) is insufficient for the development of a papilloma in
mouse skin carcinogenesis, and it is quite clear that rodent
cells are much less stable than human cells, then it may be
that the development of a colorectal adenoma may require
more than a simple loss of one FAP allele. If this is correct
then the development of an adenoma may require the pres-
ence of a colonic tumour promoter. If this were the case, it
would imply that the putative promoter of colonic carcino-
genesis, at least to the stage of the formation of an FAP
adenoma, is a compound found in every human intestine
since all FAP patients regardless of diet and geography
appear to produce many polyps. This constitutively produced
promoter could be a common physiological/dietary factor
such as the bile/fatty acids. It is, of course, possible that the
mouse skin model is not an appropriate analogy for colo-
rectal carcinogenesis and that an event different from tumour
promotion is required for the formation of an adenoma, such
as a second mutation but in a different locus to the FAP.
When considering the development of adenomas and
carcinomas in hereditary FAP patients it is important to
remember that every cell in the colon (indeed in the body) is
heterozygous at the FAP locus. Because each cell is hetero-
zygous this has led to the belief that simply by chance there
is an increased risk of the development of an adenoma
because of the high number of 'initiated' or altered target
cells, thus making it inevitable that at least one or more of
these 'initiated' cells will acquire the remaining hit(s) neces-
sary for tumour formation. This would be the case whether a
further genetic change (although not at the same locus) or
tumour promotion is necessary for the development of the
benign tumour. However, another possibly important factor
is that in hereditary patients each cell as well as being
heterozygous at the FAP locus is surrounded by cells heter-
ozygous at the same locus (Figure la). In this situation there
are no surrounding normal cells, either epithelial nor stromal,
to restrain or suppress the growth of the FAP cells (Figure
la). In the case of sporadic patients rare somatic mutations
giving rise to heterozygosity at the FAP locus or any other
putative locus will result in altered cells which are sur-
rounded by normal cells (Figure lb). Even in the possible
situation where there is only one stem cell per crypt (and
every epithelial cell in this crypt will therefore become heter-
ozygous after a somatic mutation) the initiated/altered cell in
the sporadic patients may be suppressed by surrounding
normal cells such as the muscularis mucosa/pericryptal cells
or epithelial cells from surrounding crypts (Figure lb). In this
case the surrounding influence of the normal cells may make
it less likely for the sporadic heterozygous cell to progress to
an adenoma.
In sporadic patients therefore the action of a tumour
promoter and/or another genetic event may be necessary to
allow clonal expansion of the altered cell. This would imply
that the local environment within the colon of an FAP
patient is more amenable to the growth of the heterozygous
cells than the local environment surrounding a heterozygous
sporadic cell in a normal colon. Under these conditions
therefore it is possible that in the FAP patients the develop-
ment of the adenomas may not require either a further
genetic change or tumour promoters (because they do not
require tumour promoters for clonal expansion) whereas in
sporadic patients one or more of these other events is neces-
sary.
The importance of the local microenvironment and cell-
cell interactions in the control of growth and differentiation
in normal and neoplastic cells is emphasised in a number of
recent reports (Klambt et al., 1989; Pignatelli & Bodmer,
1988; Pierce & Speers, 1988). Of particular interest is the
report that the putative tumour suppressor gene on
chromosome 18(q) implicated in colorectal carcinogenesis has
homology to neural cell adhesion molecules and other related
cell surface glycoproteins (Fearon et al., 1990).
One of the remarkable features of inherited cancer syn-
dromes is their tissue specificity but the reasons for this
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Figure 1 a, Diagrammatic representation of two crypts from an
FAP patient. Note that the epithelial cells can be under the
influence of: adjacent epithelial cells from the same crypt and/or
surrounding epithelial cells from other crypts; pericryptal cells
which are normally lining the epithelial sheet of cells (and other
cells in the lamina propria); muscularis mucosa. In the hereditary
patients every cell is heterozygous at the FAP locus and therefore
there are no normal cells to suppress or restrain the heterozygous
FAP cells. Arrows represent 'weak' or absent suppressing action
of surrounding stomal cells which are all heterozygous. These
arrows can also exist between the epithelial cells within a crypt
and between different crypts. b, Diagrammatic representation of
two crypts from a sporadic patient. The first crypt is the situation
where there is postulated to be only one stem cell in the base of a
crypt. If this is the case and this stem cell undergoes a rare
somatic mutation at the FAP locus then every cell in the crypt
will eventually be heterozygous, i.e. have one wild type and one
mutant FAP allele. In this situation the heterozygous epithelial
cells may come under the restraining influence of surrounding
non-epithelial but normal cells from the lamina propria and
muscularis mucosa and perhaps normal epithelial cells from sur-
rounding normal crypts, but not from adjacent epithelial cells in
the same crypt. The second crypt shows the situation where there
are postulated to be more than one stem cells per crypt. In this
case a rare somatic mutation at the FAP locus will result in some
but not all of the cells becoming heterozygous in the crypt. In
this situation the heterozygous 'initiated' (mutant) cells will come
under the restraining influence of the normal non-epithelial cells
described above in the case of one stem cell per crypt but also
from the remaining normal epithelial cells in the same crypt
produced by the stem cells which are not mutated at the FAP
locus. Arrows represent 'strong' suppressing action of surround-
ing stromal cells which are all homozygous wild type at the FAP
locus. These arrows can also exist between the epithelial cells
within a crypt and between different crypts.
remain unclear (Ponder, 1988). The postulation of constitu-
tive tissue specific 'tumour promoters' could, in part, explain
the tissue specificity of some inherited cancers. A naturally
occurring substance found constitutively and exclusively in a
specific (not necessarily the tumour suppressor gene product)
organ could under certain circumstances turn out to be a
tumour promoter for that organ, given appropriate muta-
tions which make those cells susceptible to promotion by the
locally produced 'tumour promoter'. The absence of the
organ (tissue) specific substance from other tissues of the
body carrying the same germ line mutation would explain the830 C. PARASKEVA & A.C. WILLIAMS
tissue specificity of the inherited cancer syndromes. Locally
produced 'growth or differentiation factors' specific to the
control of growth and differentiation of a particular tissue
many therefore under abnormal circumstances turn out to be
a tumour promoter for that same tissue. We have postulated
that the naturally occurring fatty acid sodium butyrate,
which is a potent differentiation agent, is a possible tumour
promoter in human colorectal carcinogenesis (Berry &
Paraskeva, 1988; Paraskeva et al., 1990).
Recently we have isolated sporadic and hereditary (FAP)
adenoma and carcinoma cell lines, some with ras gene muta-
tions and some without (Farr et al., 1988; Paraskeva et al.,
1984, 1989a,b). Using these cell lines we may be able to test
the importance of the local environment both in tumour
development and in tumour progression. Reconstruction
experiments involving mixing sporadic and hereditary cells of
different malignant potentials in vitro can be carried out to
determine whether the recovery of the more malignantly
advanced cells depended on the presence of putative tumour
promoters and/or whether the cells carried a ras gene muta-
tion.
In summary, although it is unclear which events are neces-
sary for the development of adenomas in both hereditary and
sporadic patients, it is possible that the local environment
surrounding a colonic cell heterozygous at the FAP locus in
an FAP patient may be quite different from a cell
heterozygous at the FAP locus due to a rare somatic muta-
tion in a sporadic patient. This possible difference in local
environment could result in less and/or different events being
involved in the development of hereditary adenomas than in
sporadic adenomas and also be in part responsible for the
high number and early onset of polyps seen in FAP patients.
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